Rivastigmine and Metabolite Analogues with Putative Alzheimer’s Disease-Modifying Properties. Dighe S.N., E. De la Mora, S. Chan, S. Kantham, G. McColl, Z.D. Nessar, S.K. Veliyath, J.A. Miles, I. Silman, J.L. Sussman, M. Weik, R.P. McGeary, M.-O. Parat, X. Brazzolotto, B.P. Ross. Accepted for publication 18/02/19, Communications Chemistry 2:35, 2019. doi: 10.1038/s42004-019-0133-4.

Effect of the biphenyl neolignan honokiol on Aβ42-induced toxicity in Caenorhabditis elegans, Aβ42 fibrillation, cholinesterase activity, DPPH radicals, and iron(II) chelation. Kantham S., S. Chan, G. McColl, J.A. Miles, S.K. Veliyath, G.S. Deora, S.N. Dighe, S. Khabbazi, M.O. Parat, B.P. Ross. ACS Chem. Neurosci. 8(9): 1901-12, 2017 doi: 10.1021/acschemneuro.7b00071 (IF 3.883).

Multifunctional analogs of kynurenic acid for the treatment of Alzheimer’s disease: Synthesis, pharmacology and molecular modeling studies. Deora G.S., S. Kantham, S. Chan, S.N. Dighe, S.K Veliyath, G. McColl, M.-O. Parat, R.P. McGeary, B.P. Ross. ACS Chem. Neurosci. 8(12):2667-75, 2017 doi: 10.1021/acschemneuro.7b00229 (IF 3.883).

Bifunctional succinylated ε-polylysine coated mesoporous silica nanoparticles for pH-responsive and intracellular drug delivery targeting the colon. Nguyen C.T.H, R.I. Webb, L.K. Lambert, E. Strounina, E.C. Lee, M.-O. Parat, M.A. McGuckin, A. Popat, P.J. Cabot, B.P. Ross. ACS Appl. Mater. Interfaces, 9(11) 9470-83, 2017 DOI:10.1021/acsami.7b00411 (IF 7.504).

Discovery and structure-activity relationships of a highly selective butyrylcholinesterase inhibitor by structure-based virtual screening. Dighe S.N., G.S. Deora, E. De la Mora, F. Nachon, S. Chan, M.-O. Parat, X. Brazzolotto, B.P. Ross. J. Med Chem 59(16):7683-9, 2016 – doi:10.1021/acs.jmedchem.6b00356 (IF 6.259).